Transcript Track B Report Final - ICASA 2015 Zimbabwe

Track B
Clinical Science, Treatment and Care
TRACK B TEAM MEMBERS
•
•
•
•
•
•
•
•
ZIMBABWE
Rumbi Dahwa (Lead Rapporteur)
Azza Mashumba
Simba Pfumojena
Patience Kuona
Cleophas Chimbetete
Emily Vera
Thenjiwe Ngwenya
BENIN
Parsifal Logbo
3
4
SESSIONS
• 6 sessions
• Total number of presentations =27
5
Session 1 -Putting Children First ,the right to
ART”
• Uganda - “test & treat” ART policy in 2013 for children <15 years .Increase
in the number of children on ART through treatment simplification &
removal of programmatic barriers. James EP et al
• Sept 2015 WHO treatment guidelines - starting ART on everyone with HIV
at any CD4 count.
• HCWs must be aware of the seroreversion phenomena to avoid
misclassification of virologically suppressed children as uninfected.
• Studies from West Africa highlighted the high frequency of ARV drug
resistance amongst children Mouneroul S et al
• New ARV drugs need to be developed for children with drug resistant
virus . Mariam S et al
Ndapewa H et al
6
Session 2 Beyond HIV infection, co-morbidities
• 1 in 3 women screened with VIAC have cervical disease: High burden of
cervical dysplasia in HIV infected women reiterates why screening should be
MANDATORY in clinics
Pascoe M et al
• Early cART for children decreases incidence of severe morbidity and
hospitalisation by mainly decreasing recurrent bacterial infections: eART
reduces healthcare costs in the long term Eboua et al
7
Session 3 Enhancing comprehensive care and support for
children and adolescents
• Community participation in food banking improves
nutritional status of orphans and vulnerable children living
with HIV in food insecure regions
Akulima et al
• Improving nutrition counseling skills of middle level health care
practitioners positively impacts nutrition outcomes in children
Sunguya et al
• Comprehensive psychosocial, treatment and care packages
improve outcomes in adolescents living with HIV
Hrapcak et al
8
Session 4 HIV / TB tango: Are we winning the war?
• Anani et al reported that INH prophylaxis did not increase
risk of emergence of Mono / Multi drug resistant TB among
incident cases
• Training and Mentorship activities are not enough to
improve TB / HIV integration . Continued activities are
required (Jeri et al)
• Attrition rates are highest among correctional services
inmates who are leaving or changing correctional facilities
(Zishiri et al)
9
Session 5 Retaining patients in HIV treatment ,
whats new?
• Sulfamethoxazole / Trimethoprim / Isoniazid / Pyridoxine
combination is bioequivalent to individual formulations.
(REALITY TRIAL) Bwakura-Dangarembizi M et al
• 6 month ARV refill for stable HIV patients improve the
retention in care including during the Ebola crisis Reinaldo
O et al
10
Session 6 From first line to functional cure?
• Gene therapy has the potential to provide a functional cure for HIV
however high cost may limit its use in Africa Garyl B et al
• Swaziland -“Test & Treat” , good treatment outcomes and high levels
of acceptance by patients Bernhardl K et al
11
THANK YOU
12